TABLE 2:

Association between self-reported 3-day adherence and viral suppression at last test among transgender women living with HIV and receiving medical care, Medical Monitoring Project, 2009 – 2013

	Total (N=258)		Viral Load<200 at last test (N=199)
	n	Column % (95% CI)	n	Row % (95% CI)	PR (95% CI)
100% Dose Adherent
Yes	209	80.5 (75.2-85.8)	175	85.2 (80.2-90.2)	1.69 (1.20-2.38)
No	44	19.5 (14.2-24.8)	21	50.4 (33.1-67.8)	Reference
100% Schedule Adherent
Yes	186	70.7 (64.0-77.4)	155	83.8 (78.1-89.5)	1.32 (1.09-1.59)
No	72	29.3 (22.6-36.0)	44	63.6 (52.2-75.0)	Reference
100% Instruction Adherent
Yes	121	66.5 (58.4-74.6)	96	79.6 (70.7-88.6)	1.14 (0.92-1.41)
No	58	33.5 (25.4-41.6)	40	70.0 (58.2-81.7)	Reference
100% Dose, Schedule, and Instruction Adherent
Yes	144	56.1 (48.8-63.4)	121	85.5 (79.3-91.6)	1.25 (1.08-1.45)
No	105	43.9 (36.6-51.2)	71	68.3 (59.1-77.5)	Reference

Note:

Numbers might not add to the total because of missing data. “Dose adherent” was defined as taking 100% of prescribed ART doses in the past 3 days, “schedule adherent” was defined as taking all ART doses according to one’s prescribed schedule in the past 3 days (e.g., 2 times a day), and “instruction adherent” was defined as following all special instructions for taking their antiretroviral medicines in the past 3 days (e.g., take with food). Instruction adherence was calculated only for participants who had special instructions for taking medications. N=unweighted sample size; All percentages were weighted. Abbreviations: PR = prevalence ratio; CI = confidence interval